A Multicenter Prospective Clinical Cohort Study on the Pathogen Spectrum of Severe Hepatitis (Liver Failure) Complicated With Infection

ConditionLiver Failure
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorZhejiang University

About this trial

The goal of this observational study is to expound the population and characteristics of pathogenic microorganisms with co-infection, draw the pedigree of pathogenic microorganisms, and evaluate its influence on disease outcome in patients with severe hepatitis (liver failure). The main questions it aims to answer are:

* Mapping of infectious agents in patients with severe hepatitis (liver failure) * Constructing early warning predictive models to explore how to give an individualized regimen of integrated immune function.

Eligibility criteria

Qualifiers

Patients agreed to participate in the study and signed an informed consent form;

Sex is not limited and age is 18-70 years old;

HBsAg positive for more than 6 months, or hepatitis E IgM positive, or hepatitis E RNA positive;

Progressive deepening of jaundice in a short period of time (serum total bilirubin greater than 10 times the upper limit of normal or rising ≥17.1 umol/L per day);

Disqualifiers

Patients with severe hepatitis caused by other non-hepatophilic viral infections;

Patients who were considered by the investigator to be unsuitable for participation in the study.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

This trial has no locations

Sponsors and collaborators

Zhejiang University

Lead sponsor

Beijing Ditan Hospital

Collaborator

Beijing YouAn Hospital

Collaborator

Huashan Hospital

Collaborator

Qilu Hospital of Shandong University

Collaborator